Global cancer statistics, 2012

Ca-A Cancer Journal for Clinicians - Tập 65 Số 2 - Trang 87-108 - 2015
Lindsey A. Torre1, Freddie Bray2, Rebecca L. Siegel3, Jacques Ferlay4, Joannie Lortet‐Tieulent5, Ahmedin Jemal6
1Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA
2Head, Section of Cancer Surveillance International Agency for Research on Cancer Lyon France
3Director of Surveillance Information, Surveillance and Health Services Research American Cancer Society Atlanta GA
4Informatics Officer, Section of Cancer Surveillance International Agency for Research on Cancer Lyon France
5Senior Epidemiologist, Surveillance and Health Services Research American Cancer Society Atlanta GA
6Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA

Tóm tắt

AbstractCancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests. CA Cancer J Clin 2015;65: 87–108. © 2015 American Cancer Society.

Từ khóa


Tài liệu tham khảo

FerlayJ SoerjomataramI ErvikM et al; International Agency for Research on Cancer. GLOBOCAN 2012 v1.0 Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11.globocan.iarc.fr. Accessed December 12 2013.

World Health Organization. Health Statistics and Information Systems: WHO Mortality Database.who.int/healthinfo/mortality_data/en/. Accessed November 6 2014.

10.1002/ijc.29210

FormanD BrayF BrewsterDH Gombe MbalawaC et al eds; International Agency for Research on Cancer. Cancer Incidence in Five Continents. Vol X. ci5.iarc.fr. Accessed December 9 2013.

Curado MP, 2007, Cancer Incidence in Five Continents. Vol IX. IARC Scientific Pub. No. 160

Mathers CD, 2005, Counting the dead and what they died from: an assessment of the global status of cause of death data, Bull World Health Organ, 83, 171

United Nations Department of Economic and Social Affairs Population Division Population Estimates and Projections Section. World Population Prospects The 2012 Revision. Definition of Regions.esa.un.org/unpd/wpp/Excel‐Data/definition‐of‐regions.htm. Accessed March 1 2014.

10.1002/ijc.2910020310

Segi M, 1960, Cancer Mortality for Selected Sites in 24 Countries (1950‐57)

10.1038/nrc1781

10.1016/S1470-2045(12)70137-7

10.1093/acprof:oso/9780195149616.003.0051

10.1093/jnci/djt043

10.1093/ije/dyh414

10.5694/j.1326-5377.2008.tb01821.x

10.1016/j.ejca.2009.01.016

Seradour B, 2009, Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006, Bull Cancer, 96, E1

10.1007/s10549-008-0226-8

10.3322/caac.20134

10.1056/NEJMsr070105

10.1016/j.canep.2012.02.007

10.1016/j.breast.2011.08.001

10.1136/bmj.d4411

10.1056/NEJMoa050518

Parkin DM, 2005, Cancer Incidence in Five Continents. Vol I to VIII. CancerBase No. 7

10.1038/nrc1784

10.1158/1055-9965.EPI-10-0437

10.1111/j.1349-7006.2009.01311.x

10.3322/caac.20140

10.1016/S1470-2045(11)70031-6

10.1158/1055-9965.EPI-09-0090

10.1002/cncr.24760

10.3322/caac.20038

10.1002/ijc.25653

10.1093/annonc/mdt301

10.1093/annonc/mdu206

10.1001/jama.2008.839

10.1002/ijc.22966

10.1093/acprof:oso/9780195149616.003.0042

10.1016/j.bpg.2007.09.004

10.1056/NEJMoa1311194

US Food and Drug Administration. FDA Approves First Non‐Invasive DNA Screening Test for Colorectal Cancer.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409021.htm. Accessed November 10 2014.

10.1002/ijc.24371

10.1136/bmjopen-2013-003671

International Agency for Research on Cancer, 2012, Personal Habits and Indoor Combustions. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

10.1093/acprof:oso/9780195149616.003.0033

10.1289/ehp/1408092

Straif K, 2013, Air Pollution and Cancer. IARC Scientific Pub. No. 161

10.1002/ijc.24855

10.1136/tobaccocontrol-2011-050294

10.1097/JTO.0b013e31818020eb

10.1016/j.lungcan.2012.08.008

10.1016/j.lungcan.2013.01.020

American Cancer Society, 2013, Cancer Facts & Figures 2013

10.1158/1055-9965.EPI-13-1220

Lam WK, 2004, Lung cancer epidemiology and risk factors in Asia and Africa, Int J Tuberc Lung Dis, 8, 1045

10.1038/nrc2703

10.1093/jnci/djn389

Centers for Disease Control and Prevention, 2011, State‐specific trends in lung cancer incidence and smoking–United States, 1999‐2008, MMWR Morb Mortal Wkly Rep, 60, 1243

10.1016/S0140-6736(12)61085-X

10.1056/NEJMoa1102873

10.3322/caac.21174

World Health Organization. Early Detection: Screening for Various Cancers.who.int/cancer/detection/variouscancer/en/index.html. Accessed February 28 2013.

10.1016/j.eururo.2012.02.054

10.1155/2013/560857

10.1002/mnfr.200700511

10.1016/S1470-2045(14)70211-6

10.3892/ol.2014.2388

10.1093/jnci/djp001

10.1002/cncr.28932

10.1002/ijc.21731

10.1002/ijc.28999

10.1093/oxfordjournals.epirev.a036288

10.1016/j.annepidem.2010.08.013

10.1002/ijc.24290

10.1001/jama.2014.10498

10.1093/acprof:oso/9780195149616.003.0039

10.1111/j.1349-7006.2009.01458.x

AverhoffF; Centers for Disease Control and Prevention. Infectious Diseases Related to Travel: Hepatitis B.cdc.gov/travel/yellowbook/2014/chapter‐3‐infectious‐diseases‐related‐to‐travel/hepatitis‐b. Accessed November 4 2014.

International Agency for Research on Cancer, 2002, Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans

10.1056/NEJMra1001683

10.1097/MCG.0b013e3182872f29

Howlader N, 2014, SEER Cancer Statistics Review, 1975‐2011

10.1200/JCO.2008.20.7753

10.1158/1055-9965.EPI-11-0643

10.1001/jama.2013.276701

10.3748/wjg.v19.i47.8887

Centers for Disease Control and Prevention. CDC Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945‐1965.cdc.gov/hepatitis/HCV/1945‐1965.htm. Accessed September 25 2014.

10.7314/APJCP.2013.14.11.7039

10.1002/jhbp.62

10.1016/j.ejca.2013.04.024

10.1086/657321

10.1016/j.vaccine.2012.07.055

EngholmG FerlayJ ChristensenN et al; Association of the Nordic Cancer Registries; Danish Cancer Society. NORDCAN: Cancer Incidence Mortality Prevalence and Survival in the Nordic Countries. Version 6.1 (25.04.2014).ancr.nu. Accessed September 16 2014.

10.1016/j.vaccine.2013.02.071

GAVI. Millions of Girls in Developing Countries to be Protected Against Cervical Cancer Thanks to New HPV Vaccine Deals.gavi.org/library/news/press‐releases/2013/hpv‐price‐announcement/. Accessed September 12 2014.

10.1016/j.bpobgyn.2011.11.004

10.1056/NEJMoa0808516

10.1038/sj.bjc.6601737

10.1002/ijc.20616

10.1002/ijc.24445

10.1136/bmj.b929

10.1177/030089161209800203

10.1002/ijc.24142

10.1371/journal.pone.0069238

10.1038/bjc.2014.96

10.1016/j.annepidem.2013.07.002

10.1093/jnci/djr499

10.1001/jama.2013.226450

10.1007/s10552-009-9458-0

10.1093/annonc/mdt486

10.1155/2012/649108

10.1038/sj.bjc.6605246

10.1016/S0140-6736(12)60643-6

10.1158/1940-6207.CAPR-08-0109

10.3748/wjg.v19.i36.6098

10.3322/caac.21185

10.1097/MOG.0000000000000090

10.1038/ajg.2014.156

10.1016/j.eururo.2013.10.001

10.1080/03008880802285032

Institute for Health Metrics and Evaluation, 2013, GBD Cause Patterns

10.1093/jnci/djs491

10.1093/annonc/mds069

10.1016/0140-6736(91)92513-2

Devesa SS, 1992, Non‐Hodgkin's lymphoma time trends: United States and international data, Cancer Res, 52, 5432s

Hartge P, 1992, Quantification of the impact of known risk factors on time trends in non‐Hodgkin's lymphoma incidence, Cancer Res, 52, 5566s

10.1093/jnci/94.16.1204

10.1002/ijc.28661

10.1002/ijc.28063

10.1158/1055-9965.EPI-08-0347

Blot WJ, 1988, Smoking and drinking in relation to oral and pharyngeal cancer, Cancer Res, 48, 3282

10.1016/S0140-6736(05)67725-2

10.1038/sj.bjc.6604907

10.1007/s10552-010-9570-1

10.1016/j.oraloncology.2014.01.016

10.1002/ijc.24994

10.1200/JCO.2011.36.4596

10.1002/cncr.27989

Wei KR, 2014, Nasopharyngeal carcinoma incidence and mortality in China in 2010, Chin J Cancer, 33, 381

10.1016/j.ejca.2009.11.012

10.1093/acprof:oso/9780195149616.003.0031

10.1158/1055-9965.EPI-06-0353

10.1016/S1044579X02000834

Buell P, 1974, The effect of migration on the risk of nasopharyngeal cancer among Chinese, Cancer Res, 34, 1189

Henle W, 1972, Oncogenesis and Herpes Viruses, 269

10.1002/ijc.2910340506

10.1186/1471-2407-6-178

10.1158/1055-9965.EPI-05-0821

10.1002/ijc.10894

10.1007/s10654-007-9148-8

10.1093/aje/kwi345

10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.0.CO;2-9

10.1038/bjc.1998.717

Oettle AG, 1962, Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes, Acta Unio Int Contra Cancrum, 18, 330

10.1159/000397432

10.1001/jama.1993.03500060023008

10.1093/jnci/92.22.1823

10.1002/ijc.24838

UNAIDS. Access to Antiretroviral Therapy in Africa: Status Report on Progress Towards the 2015 Targets.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/unaidspublication/2013/20131219_AccessARTAfricaStatusReportProgresstowards2015Targets_en.pdf. Accessed November 3 2014.

10.1053/jinf.2000.0712

10.1056/NEJM199906173402403

10.1002/ijc.28125

10.1038/nrc1948

Thông tin
Thông tin xuất bản

Ca-A Cancer Journal for Clinicians

Tập 65 Số 2

87-108

Thông tin tác giả